|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
03/21/2024 |
$47.34 |
$47.94 |
$46.63 |
$46.65 |
473.60K | 03/22/2024 |
$46.81 |
$47.05 |
$45.56 |
$45.85 |
403.70K | 03/25/2024 |
$45.87 |
$46.31 |
$45.02 |
$45.42 |
442.70K | 03/26/2024 |
$45.97 |
$46.24 |
$45.01 |
$45.46 |
362.30K | 03/27/2024 |
$45.97 |
$47.16 |
$45.55 |
$46.82 |
551.40K |
|
Ultragenyx Pharmaceutical is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of products for the treatment of genetic diseases. Co. has four commercially approved products, Crysvita® (burosumab) for the treatment of X-linked hypophosphatemia and tumor-induced osteomalacia, Mepsevii® (vestronidase alfa) for the treatment of mucopolysaccharidosis VII, or Sly Syndrome, Dojolvi® (triheptanoin) for the treatment of long-chain fatty acid oxidation disorders, and Evkeeza® (evinacumab) for the treatment of homozygous familial hypercholesterolemia. | |
|
Ultragenyx Pharmaceutical (RARE) has the following price history information. Looking back at RARE historical stock prices for the last five trading days, on March 21, 2024, RARE opened at $47.34, traded as high as $47.94 and as low as $46.63, and closed at $46.65. Trading volume was a total of 473.60K shares. On March 22, 2024, RARE opened at $46.81, traded as high as $47.05 and as low as $45.56, and closed at $45.85. Trading volume was a total of 403.70K shares. On March 25, 2024, RARE opened at $45.87, traded as high as $46.31 and as low as $45.02, and closed at $45.42. Trading volume was a total of 442.70K shares. On March 26, 2024, RARE opened at $45.97, traded as high as $46.24 and as low as $45.01, and closed at $45.46. Trading volume was a total of 362.30K shares. On March 27, 2024, RARE opened at $45.97, traded as high as $47.16 and as low as $45.55, and closed at $46.82. Trading volume was a total of 551.40K shares.
RARE Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Ultragenyx Pharmaceutical shares, starting with a $10,000 purchase of RARE, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
03/31/2014 |
|
End date: |
03/27/2024 |
|
Start price/share: |
$48.89 |
|
End price/share: |
$46.82 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-4.23% |
|
Average Annual Total Return: |
-0.43% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$9,578.34 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
03/21/2024 | $46.65 | 03/22/2024 | $45.85 | 03/25/2024 | $45.42 | 03/26/2024 | $45.46 | 03/27/2024 | $46.82 |
|
|